My Orders
Wishlist
Help
Sell On LootLiraglutide (Paperback)
High Quality Content by WIKIPEDIA articles Liraglutide (NN2211), marketed under the brand name Victoza, is a long-acting glucagon-like peptide-1 (GLP-1) analog that has been developed by Novo Nordisk for the treatment of type 2 diabetes. The product was approved by the European Medicines Agency (EMA) on July 3, 2009, and by the U.S. Food and Drug Administration (FDA) on January 25, 2010.
R380
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
3800
Out of stock
Add to wish listReview this Item
Product Description
High Quality Content by WIKIPEDIA articles Liraglutide (NN2211), marketed under the brand name Victoza, is a long-acting glucagon-like peptide-1 (GLP-1) analog that has been developed by Novo Nordisk for the treatment of type 2 diabetes. The product was approved by the European Medicines Agency (EMA) on July 3, 2009, and by the U.S. Food and Drug Administration (FDA) on January 25, 2010.
Customer Reviews
No reviews or ratings yet - be the first to create one!
Product Details
General
Imprint | Book on Demand |
Country of origin | United States |
Release date | February 2012 |
Availability | Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available. |
First published | February 2012 |
Editors | Jesse Russell, Ronald Cohn |
Dimensions | 210 x 148 x 8mm (L x W x T) |
Format | Paperback - Trade |
Pages | 154 |
ISBN-13 | 978-5-512-67110-8 |
Barcode | 9785512671108 |
Categories | |
LSN | 5-512-67110-3 |
Similar Products | Recommended ProductsSee more 
Trending On Loot
Be the first to know about our
latest deals & promos! Subscribe Now
